Merck to create separate cancer division
Digest more
Merck is preparing to cut about 150 jobs at its new vaccine plant in Durham, North Carolina, a move that ties a very local ...
Merck, known as MSD outside the U.S. and Canada, is restructuring its Human Health organization and appointing three new ...
Merck reaches new high after earnings update, oncology restructuring, and clinical progress, highlighting position within the ...
Merck (NYSE:MRK) announced a major reorganization of its Human Health business into two global units focused on Oncology and on Specialty, Pharma & Infectious Diseases. The company named new senior ...
The winners will not be those who merely predict cliffs, but those who re-architect early enough. Merck’s oncology spin-out underscores a defining reality of modern pharma: molecules may create value, ...
As part of a restructuring plan it announced four months ago, Merck said it will eliminate 50 jobs at a site in Springfield that it gained through a merger with Schering-Plough. As part of a ...
Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches and its drug pipeline. The multiyear effort comes as Merck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results